ARTL Company Profile and Key Details

Q: Who are the executives of ARTL?

Dr. Andrew Yates Ph.D.Senior Vice President & Chief Scientific OfficerDr. Steven D. ReichChief Medical OfficerMr. Jason H. BaybuttSenior Vice President of Fin.Mr. Gregory D. Gorgas M.B.A.Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director

NASDAQ : ARTL

Artelo Biosciences

$4.85

-0.94-16.24%

At Close 4:00 PM

$4.02

−0.83-17.11%

After-Market 08:30 PM

60.16

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Artelo Biosciences, Inc. (ARTL) stock declined over -16.23%, trading at $4.85 on NASDAQ, down from the previous close of $5.79. The stock opened at $4.85, fluctuating between $4.24 and $5.78 in the recent session.

Stock Snapshot

5.79

Prev. Close

10.31M

Market Cap

4.24

Day Low

-0.13

P/E Ratio

-37.56

EPS (TTM)

-2.07

Cash Flow per Share

4.85

Open

2.12M

Number of Shares

5.78

Day High

99.37%

Free Float in %

4.94

Book Value

3.2M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 25, 2026	4.85	5.78	4.24	4.85	3.21M
Mar 24, 2026	7.21	7.59	4.65	5.79	521.15K
Mar 23, 2026	7.72	8.60	6.41	7.66	490.85K
Mar 20, 2026	8.40	9.80	7.62	7.97	11.95M
Mar 19, 2026	6.70	7.18	6.03	7.16	860.31K
Mar 18, 2026	6.12	8.34	6.08	7.31	58.38M
Mar 17, 2026	4.38	4.90	4.14	4.85	32.7K
Mar 16, 2026	3.87	4.78	3.81	4.15	131.69K
Mar 13, 2026	3.93	4.05	3.75	3.76	21.56K
Mar 12, 2026	4.03	4.41	3.88	3.90	45.01K
Mar 11, 2026	4.04	4.40	3.78	4.14	61.99K
Mar 10, 2026	3.70	4.38	3.33	4.05	121.12K
Mar 09, 2026	3.69	3.96	3.30	3.51	91.08K
Mar 06, 2026	3.57	3.75	3.30	3.42	20.2K
Mar 03, 2026	3.42	3.51	3.15	3.30	9.66K
Mar 02, 2026	3.51	3.51	3.36	3.42	6.21K
Feb 27, 2026	3.75	3.81	3.48	3.57	8.57K
Feb 26, 2026	3.81	3.96	3.63	3.72	6.46K
Feb 25, 2026	3.99	4.02	3.63	3.63	3K
Feb 24, 2026	3.72	4.20	3.72	3.90	16.39K

Contact Details

Solana Beach, CA 92075

United States

https://www.artelobio.com 858 925 7049

About Company

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Stock Peers

REGN

7.78+1.05%

Regeneron Pharmaceuticals, Inc.$749.47 ARGX

19.55+2.89%

argenx SE$697.05 UTHR

9.78+1.84%

United Therapeutics Corporation$541.60 MDGL

16.89+3.80%

Madrigal Pharmaceuticals, Inc.$461.93 VRTX

6.35+1.42%

Vertex Pharmaceuticals Incorporated$454.97 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

20.65+6.70%

Alnylam Pharmaceuticals, Inc.$328.70 PRAX

17.27+5.86%

Praxis Precision Medicines, Inc.$311.92 KRYS

7.86+3.18%

Krystal Biotech, Inc.$254.95 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Artelo Biosciences, Inc. (ARTL) stock price?

Artelo Biosciences, Inc. (NASDAQ: ARTL) stock price is $4.85 in the last trading session. During the trading session, ARTL stock reached the peak price of $5.78 while $4.24 was the lowest point it dropped to. The percentage change in ARTL stock occurred in the recent session was -16.23% while the dollar amount for the price change in ARTL stock was - $0.94.

ARTL's industry and sector of operation?

The NASDAQ listed ARTL is part of Biotechnology industry that operates in the broader Healthcare sector. Artelo Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ARTL?

Dr. Andrew Yates Ph.D.
Senior Vice President & Chief Scientific Officer
Dr. Steven D. Reich
Chief Medical Officer
Mr. Jason H. Baybutt
Senior Vice President of Fin.
Mr. Gregory D. Gorgas M.B.A.
Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director

How ARTL did perform over past 52-week?

ARTL's closing price is 53.97% higher than its 52-week low of $3.15 where as its distance from 52-week high of $85.80 is -94.35%.

How many employees does ARTL have?

Number of ARTL employees currently stands at 6.

Link for ARTL official website?

Official Website of ARTL is: https://www.artelobio.com

How do I contact ARTL?

ARTL could be contacted at phone 858 925 7049 and can also be accessed through its website. ARTL operates from 505 Lomas Santa Fe, Solana Beach, CA 92075, United States.

How many shares of ARTL are traded daily?

ARTL stock volume for the day was 3.2M shares. The average number of ARTL shares traded daily for last 3 months was 1.25M.

What is the market cap of ARTL currently?

The market value of ARTL currently stands at $10.31M with its latest stock price at $4.85 and 2.12M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	6
Beta	1.07
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	6
Beta	1.07
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ARTL Company Profile and Key Details

Artelo Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics